Pfizer to seek FDA approval of boosters for teens ages 16-17
Sources of information influence COVID-19 knowledge, protective behaviors
30 November 2021Irregular heartbeat risk linked to frequent alcohol use in people under 40
30 November 2021Pfizer to seek FDA approval of boosters for teens ages 16-17
(HealthDay)—Pfizer Inc. is expected to seek approval this week for emergency use of its booster shots among American teens ages 16-17.
